Log in or Sign up for Free to view tailored content for your specialty!
Diabetes Education News
Semaglutide may reduce overdose risk in those with diabetes, opioid use disorder
Adults with type 2 diabetes and opioid use disorder who received semaglutide had significantly lower risk for opioid overdose compared with those taking other diabetes medications, a research letter in JAMA Network Open showed.
Diabetes drug linked to reduced risk for dementia, Parkinson’s disease
The use of sodium-glucose cotransporter 2 inhibitors reduced the risk for multiple neurodegenerative diseases in adults with type 2 diabetes, according to study results published in Neurology.
Log in or Sign up for Free to view tailored content for your specialty!
Prediabetes before conception tied to higher risk for adverse pregnancy outcomes
Adolescent and young adult women who had prediabetes before becoming pregnant had a higher risk for gestational diabetes and adverse maternal outcomes than those with normal glycemic levels, researchers reported.
Children, adults more likely to develop type 1 diabetes if father has disease vs. mother
Both children and adults are more likely to be diagnosed with type 1 diabetes if they have a father with type 1 diabetes vs. a mother with the condition, according to a speaker.
FTC files administrative complaint vs. PBMs alleging artificially inflated insulin prices
The Federal Trade Commission announced it has filed an administrative complaint against three pharmacy benefit managers alleging “anticompetitive and unfair” rebate practices that have artificially inflated the price of insulin drugs.
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
In a small study of patients with type 1 diabetes using an automated insulin delivery system, semaglutide improved glucose control vs. placebo, researchers reported at the European Association for the Study of Diabetes Annual Meeting.
Off-label semaglutide, tirzepatide lower HbA1c and body weight in type 1 diabetes
Adults with type 1 diabetes using either semaglutide or tirzepatide off-label had greater decreases in body weight and HbA1c than those not treated with either medication, according to a speaker.
Metformin use may lower risk for long COVID in adults with type 2 diabetes
Adults with type 2 diabetes using metformin before or during a SARS-CoV-2 infection may have a lower risk for long COVID than those using other diabetes medications, according to findings published in Diabetes Care.
Sotagliflozin improves time in range in basal insulin-treated type 2 diabetes
In patients with basal insulin-treated type 2 diabetes, sotagliflozin was associated with greater time in range compared with placebo at 18 weeks, researchers reported at the European Association for the Study of Diabetes Annual Meeting.
Future of AI could mean streamlined clinical care, better connection with patients
Use of AI in medicine is growing quickly. Clinicians are eager to learn what the technology can do, and speakers at meetings across specialties are envisioning its effects — good and bad — in practice management and patient care.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read